Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
RegeneRx Licensee Acquired by Korean Biopharmaceutical Group
Tuesday, September 28, 2021RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration today announced that GtreeBNT the licensee for several RegeneRx products is being acquired by HLB Group a Korean company tha...
Bio-Thera Solutions and Intract Pharma Enter Global Collaboration and License Agreement for Soteria® and Phloral® Drug Delivery Technologies to Enable Development of Oral Antibody Medicines
Tuesday, September 28, 2021BioThera Solutions Ltd and Intract Pharma announced a global collaboration and licensing agreement that gives BioThera access to Intracts Soteria and Phloral drug delivery technologies to develop novel oral monoclonal antibody mAb treatments for chro...
Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002
Monday, September 27, 2021Transcenta Holding Limited a clinical stage biopharmaceutical company with fullyintegrated capabilities in discovery research development and manufacturing of antibodybased therapeutics announces that it received IND clearance on Sept from NMPA for...
AstraZeneca and Oncoshot establish strategic partnership to better streamline recruitment process for cancer clinical trials
Friday, September 24, 2021Amnio Technology LLC a global leader in the development and distribution of amniotic tissue allografts is announcing today that the United States Patent and Trademark Office has issued a new patent titled Enriched Multilayer Amnion Derived Tissue Gra...
Phenomenex Announces the Release of New Biozen® SEC Size Exclusion Chromatography Columns
Friday, September 24, 2021Phenomenex Inc a global leader in the research and manufacture of advanced technologies for the separation sciences announces the successful launch of NEW Biozen SEC Size Exclusion Chromatography Columns to the existing Biozen portfolio of biological...
Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine Booster
Thursday, September 23, 2021Pfizer Inc and BioNTech SE announced that the US Food and Drug Administration FDA has authorized for emergency use a booster dose of the PfizerBioNTech COVID Vaccine for individuals years of age and older individuals through years of age at high r...
AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies
Thursday, September 23, 2021AbCellera and Everest Medicines Limited announced that they have entered into a multiyear collaboration and license agreement to discover therapeutic antibodies for up to targets selected by Everest The partnership will help to expand Everests portf...
Persephone Biosciences Inc. Announces Collaboration with Janssen Biotech, Inc.
Wednesday, September 22, 2021Persephone Biosciences Inc a privately held datadriven microbiomefocused biotechnology company today announced that it has entered into a collaboration agreement with Janssen Biotech Inc Janssen one of the Janssen Pharmaceutical Companies of Johnson...
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
Wednesday, September 22, 2021Mayne Pharma is pleased to announce that the US Food and Drug Administration FDA has approved LEXETTE halobetasol propionate foam for use in adolescents LEXETTE a super potent topical corticosteroid is now approved for the treatment of plaque psoria...
Boehringer Ingelheim and Oxford BioTherapeutics Partnership Advances Second Oncology Drug Candidate into the Clinic
Tuesday, September 21, 2021Oxford BioTherapeutics OBT a clinical stage oncology company with a pipeline of immunooncology and ADCbased therapies today announced that it has received another milestone payment from Boehringer Ingelheim BI for the progress of a second oncology dr...
